EGFR and glioblastoma: We compared the prognosis of patients with GBM-IDHwt with high-grade histologic features such as MVP or necrosis (classic GBM) with that of patients diagnosed with GBM-IDHwt due to the presence of TERTp or EGFR mutations, although, histologically classified as low-grade (so-called molecular GBM).